Literature DB >> 31528514

Fluorouracil (5-FU)-induced Cardiomyopathy.

Nishanth Thalambedu1, Yasir Khan1.   

Abstract

Fluorouracil (5-FU) is a pyrimidine analog widely used in oncology. It is mainly used in the treatment of solid tumors. It is also used along with radiotherapy because of its radiosensitizing properties. As with all chemotherapy drugs, 5-FU is associated with adverse effects. Cardiotoxicity is one of them. It can present in a variety of ways and, sometimes, it can be lethal too. The reported case is of a 42-year-old male who presented with atypical chest pain after the first dose of 5-FU and was finally diagnosed with 5-FU-induced cardiotoxicity. His cardiac function normalized after the withdrawal of the drug.

Entities:  

Keywords:  5-fluorouracil; cardiotoxicity; fluoropyrimidine; rectal cancer

Year:  2019        PMID: 31528514      PMCID: PMC6743662          DOI: 10.7759/cureus.5162

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  3 in total

1.  Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer.

Authors:  A Visvikis; S M Kyvelou; P Pietri; C Georgakopoulos; K Manousou; D Tousoulis; C Stefanadis; C Vlachopoulos; D Pektasides
Journal:  Cancer Manag Res       Date:  2020-02-13       Impact factor: 3.989

2.  Myricetin (3,3',4',5,5',7-Hexahydroxyflavone) Prevents 5-Fluorouracil-Induced Cardiotoxicity.

Authors:  Azher Arafah; Muneeb U Rehman; Ajaz Ahmad; Khalid M AlKharfy; Saeed Alqahtani; Basit L Jan; Nada M Almatroudi
Journal:  ACS Omega       Date:  2022-01-25

3.  Activated ROCK/Akt/eNOS and ET-1/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin.

Authors:  Radwa Nasser Muhammad; Nada Sallam; Hanan Salah El-Abhar
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.